NC
CABA icon

NewSquare Capital’s Cabaletta Bio CABA Stock Holding History

NewSquare Capital’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed -$129 – 642
2023
Q2 		$129 Hold
10
– – ﹤0.01% 780
2023
Q1 		$83 Hold
10
– – ﹤0.01% 833
2022
Q4 		$93 Buy
+10
New +$36 ﹤0.01% 773

Other funds holding CABA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NewSquare Capital's CABA Position: Q3 2023 in Review

NewSquare Capital sold out of Cabaletta Bio (CABA) in Q3 2023, closing a stake of 10 shares — an estimated $129 sold.

NewSquare Capital first reported a position in CABA in Q4 2022 and held it in 3 quarters. The position peaked at $129 in Q2 2023. 97 funds tracked by Wall St. Rank hold CABA as of Q3 2023.

  • NewSquare Capital reported no remaining Cabaletta Bio position as of Q3 2023 after selling out during the quarter.
  • NewSquare Capital sold 10 Cabaletta Bio shares in Q3 2023, an estimated $129.
  • NewSquare Capital first reported a position in Cabaletta Bio in Q4 2022 and held it in 3 quarters.
  • NewSquare Capital's Cabaletta Bio position peaked at $129 in Q2 2023.
  • 97 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.